Journal of Clinical Endocrinology & Metabolism, Vol 81, 2726-2730, Copyright © 1996 by Endocrine Society

ARTICLES

Expression of the cell death-inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland

F Branet, P Brousset, S Krajewski, D Schlaifer, J Selves, JC Reed and P Caron
Service d'Endocrinologie, Centre Hospitalier Universitaire de Rangueil, Toulouse, France.

The expression of apoptosis-regulating proteins, Bcl-2, Bax, Mcl-1, and Bcl-X, was evaluated by immunohistochemical methods in 39 cases of thyroid carcinomas. Normal thyroid tissues showed a consistent expression of Bcl-2 and Mcl-1 whereas Bax and Bcl-X proteins were essentially absent from most follicular thyroid cells. Bax expression was observed in all papillary carcinomas (n = 23) and in 8 of 10 follicular carcinomas. The intensity of Bcl-2 immunostaining was generally higher in follicular tumors (n = 10) than in papillary carcinomas (n = 21 of 23). However, in undifferentiated tumors, both Bax and Bcl-2 were weakly expressed. Mcl-1 protein expression was similar to that of Bax in papillary and follicular tumors, but was also frequently detectable in undifferentiated tumors. Bcl-X immunostaining was seen in all undifferentiated tumors (n = 6), in 22 of 23 papillary tumors, and in 5 of 10 follicular tumors. Our findings show that the regulation of bcl-2 family gene expression is different in normal thyroid tissue compared to that of its neoplastic counterpart and varies with the tumor subtype. In particular, unlike normal thyroid epithelium, the apoptosis-blocking gene bcl-X and the apoptosis- inducing gene bax are frequently expressed in thyroid carcinomas derived from the follicular cells. Thus, alterations in the expression of these bcl-2 family genes may contribute to the pathogenesis of thyroid carcinomas.

This article has been cited by other articles:

				J. Pan, H. Huang, L. Sun, B. Fang, and S.-C. J. Yeung Bcl-2-Associated X Protein Is the Main Mediator of Manumycin A-Induced Apoptosis in Anaplastic Thyroid Cancer Cells J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3583 - 3591. [Abstract] [Full Text] [PDF]

				M. Volante, M. Papotti, P. Gugliotta, A. Migheli, and G. Bussolati Extensive DNA Fragmentation in Oxyphilic Cell Lesions of the Thyroid J. Histochem. Cytochem., August 1, 2001; 49(8): 1003 - 1012. [Abstract] [Full Text] [PDF]

				M. Koga, Y. Hiromatsu, A. Jimi, S. Toda, N. Koike, and K. Nonaka Immunohistochemical Analysis of Bcl-2, Bax, and Bak Expression in Thyroid Glands from Patients with Subacute Thyroiditis J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2221 - 2225. [Abstract] [Full Text]

				C. Riou, H. Tonoli, F. Bernier-Valentin, R. Rabilloud, P. Fonlupt, and B. Rousset Susceptibility of Differentiated Thyrocytes in Primary Culture to Undergo Apoptosis after Exposure to Hydrogen Peroxide: Relation with the Level of Expression of Apoptosis Regulatory Proteins, Bcl-2 and Bax Endocrinology, May 1, 1999; 140(5): 1990 - 1997. [Abstract] [Full Text]

				Y.-T. Tai, T. Strobel, D. Kufe, and S. A. Cannistra In Vivo Cytotoxicity of Ovarian Cancer Cells through Tumor-selective Expression of the BAX Gene Cancer Res., May 1, 1999; 59(9): 2121 - 2126. [Abstract] [Full Text] [PDF]

				S. H. Wang, R. J. Koenig, T. J. Giordano, A. Myc, N. W. Thompson, and J. R. Baker Jr. 1{alpha},25-Dihydroxyvitamin D3 Up-Regulates Bcl-2 Expression and Protects Normal Human Thyrocytes from Programmed Cell Death Endocrinology, April 1, 1999; 140(4): 1649 - 1656. [Abstract] [Full Text]

				E. Kulig, L. Jin, X. Qian, E. Horvath, K. Kovacs, L. Stefaneanu, B. W. Scheithauer, and R. V. Lloyd Apoptosis in Nontumorous and Neoplastic Human Pituitaries : Expression of the Bcl-2 Family of Proteins Am. J. Pathol., March 1, 1999; 154(3): 767 - 774. [Abstract] [Full Text] [PDF]